|Structural Type:||[ ]|
|Functional Type:||[ ]|
Shared Reference Notes
- [1.1] [#Breast cancer]
- Enterolactone may act as a selective modulator of estrogen signaling and may be associated with lowering the risk of BC.
- [#Breast cancer] [#Antibiotic Therapy] - Overuse of antibiotics might reduce the plasma level of lignan enterolactone; therefore, it might directly affect the microbiome populations and increase the BC risk